BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8616027)

  • 1. Serum LDH value as a predictor of clinical outcome in acute myelogenous leukaemia of the elderly.
    Ferrara F; Mirto S
    Br J Haematol; 1996 Mar; 92(3):627-31. PubMed ID: 8616027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum LDH, a prognostic factor in elderly patients with acute myelogenous leukaemia.
    Dalley CD; Lister TA; Cavenagh JD; Rohatiner AZ
    Br J Cancer; 2001 Jan; 84(1):147. PubMed ID: 11139330
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevated lactate dehydrogenase is an adverse predictor of outcome in HLA-matched sibling bone marrow transplant for acute myelogenous leukemia.
    Kalaycio M; Rybicki L; Pohlman B; Dean R; Sweetenham J; Andresen S; Sobecks R; Sekeres MA; Advani A; Brown S; Bolwell B
    Bone Marrow Transplant; 2007 Oct; 40(8):753-8. PubMed ID: 17700600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment risk factors and importance of comorbidity for overall survival, complete remission, and early death in patients with acute myeloid leukemia.
    Djunic I; Virijevic M; Novkovic A; Djurasinovic V; Colovic N; Vidovic A; Suvajdzic-Vukovic N; Tomin D
    Hematology; 2012 Mar; 17(2):53-8. PubMed ID: 22664041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of angiogenic factors in patients with acute or chronic leukemia: hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia.
    Kim JG; Sohn SK; Kim DH; Baek JH; Lee NY; Suh JS; Chae SC; Lee KS; Lee KB
    Leuk Lymphoma; 2005 Jun; 46(6):885-91. PubMed ID: 16019534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to salvage therapy and survival after relapse in acute myelogenous leukemia.
    Keating MJ; Kantarjian H; Smith TL; Estey E; Walters R; Andersson B; Beran M; McCredie KB; Freireich EJ
    J Clin Oncol; 1989 Aug; 7(8):1071-80. PubMed ID: 2666590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia in the elderly: a critical review of therapeutic approaches and appraisal of results of therapy.
    Ferrara F; Mirto S; Zagonel V; Pinto A
    Leuk Lymphoma; 1998 Apr; 29(3-4):375-82. PubMed ID: 9684934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactate dehydrogenase, not vascular endothelial growth factor or basic fibroblast growth factor, positively correlates to bone marrow vascularity in acute myeloid leukemia.
    Teng CL; Young JH; Hsu SL; Chou G; Kuo IT; Yu CY; Hwang GY
    J Chin Med Assoc; 2006 Nov; 69(11):534-7. PubMed ID: 17116616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of elderly acute myeloid leukemia patients for intensive chemotherapy: effectiveness of intensive chemotherapy and subgroup analysis.
    Kim DS; Kang KW; Yu ES; Kim HJ; Kim JS; Lee SR; Park Y; Sung HJ; Yoon SY; Choi CW; Kim BS
    Acta Haematol; 2015; 133(3):300-9. PubMed ID: 25470986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stratification of de novo adult acute myelogenous leukemia with adverse-risk karyotype: can we overcome the worse prognosis of adverse-risk group acute myelogenous leukemia with hematopoietic stem cell transplantation?
    Yoon JH; Kim HJ; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):80-8. PubMed ID: 24149098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early recovery of the platelet count after decitabine-based induction chemotherapy is a prognostic marker of superior response in elderly patients with newly diagnosed acute myeloid leukaemia.
    Huang J; Zhao H; Hong M; Zhu H; Zhu Y; Lian Y; Li S; Li J; Qian S
    BMC Cancer; 2018 Dec; 18(1):1269. PubMed ID: 30567513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for therapy-related acute myeloid leukaemia (t-AML)--a single centre experience.
    Suvajdžić N; Cvetković Z; Dorđević V; Kraguljac-Kurtović N; Stanisavljević D; Bogdanović A; Djunić I; Colović N; Vidović A; Elezović I; Tomin D
    Biomed Pharmacother; 2012 Jun; 66(4):285-92. PubMed ID: 22401928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core binding factor acute myeloid leukaemia and c-KIT mutations.
    Riera L; Marmont F; Toppino D; Frairia C; Sismondi F; Audisio E; Di Bello C; D'Ardia S; Di Celle PF; Messa E; Inghirami G; Vitolo U; Pich A
    Oncol Rep; 2013 May; 29(5):1867-72. PubMed ID: 23467883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factor analysis of 77 old patients with acute myelogenous leukemia].
    Shao B; Gao YR; Wang C; Yan SK; Cai Q; Jiang JL; Yang J; Bai HT; Zhao M; Zhao CX
    Ai Zheng; 2006 Aug; 25(8):1007-12. PubMed ID: 16965684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between serum lactate dehydrogenase and 60-day mortality in Chinese Hakka patients with acute myeloid leukemia: A cohort study.
    Xiao Z; Gong R; Chen X; Xiao D; Luo S; Ji Y
    J Clin Lab Anal; 2021 Dec; 35(12):e24049. PubMed ID: 34708888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoenzymes in plasma of acute leukaemia patients: prevention of anthracycline cardiomyopathy.
    Kothe K; Stobbe H; Gola G; Wagenknecht C
    Haematologia (Budap); 1985; 18(3):165-73. PubMed ID: 3869808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib.
    Faloppi L; Bianconi M; Giampieri R; Sobrero A; Labianca R; Ferrari D; Barni S; Aitini E; Zaniboni A; Boni C; Caprioni F; Mosconi S; Fanello S; Berardi R; Bittoni A; Andrikou K; Cinquini M; Torri V; Scartozzi M; Cascinu S;
    Oncotarget; 2015 Oct; 6(33):35087-94. PubMed ID: 26397228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myelogenous leukaemia in older patients at St Bartholomew's Hospital: outcome with mitoxantrone and cytarabine.
    Dalley CD; Lillington DL; Bradburn M; Carter M; Amess JA; Rohatiner AZ; Lister TA
    Hematol J; 2002; 3(5):237-43. PubMed ID: 12391541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.